RTC
PFE icon

Riverview Trust Company’s Pfizer PFE Stock Holding History

Riverview Trust Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.01K Sell
321
-1,193
-79% -$31.8K 0.01% 170
2025
Q4 		$37.7K Sell
1,514
-2,305
-60% -$58.1K 0.05% 133
2025
Q3 		$97.3K Sell
3,819
-300
-7% -$7.41K 0.12% 96
2025
Q2 		$99.8K Sell
4,119
-12,295
-75% -$287K 0.12% 88
2025
Q1 		$416K Sell
16,414
-5,326
-24% -$139K 0.41% 48
2024
Q4 		$577K Sell
21,740
-92
-0.4% -$2.5K 0.52% 36
2024
Q3 		$632K Buy
21,832
+91
+0.4% +$2.65K 0.55% 34
2024
Q2 		$608K Buy
21,741
+4,265
+24% +$117K 0.58% 33
2024
Q1 		$485K Sell
17,476
-3,787
-18% -$105K 0.37% 47
2023
Q4 		$612K Buy
21,263
+3,537
+20% +$107K 0.62% 40
2023
Q3 		$588K Sell
17,726
-122
-0.7% -$4.31K 0.52% 40
2023
Q2 		$655K Sell
17,848
-2,658
-13% -$103K 0.59% 33
2023
Q1 		$837K Buy
20,506
+463
+2% +$20K 0.77% 27
2022
Q4 		$1.03M Sell
20,043
-2,756
-12% -$132K 0.97% 22
2022
Q3 		$998K Sell
22,799
-119
-0.5% -$5.78K 0.97% 20
2022
Q2 		$1.2M Buy
22,918
+4,061
+22% +$207K 1.05% 19
2022
Q1 		$976K Buy
18,857
+3,665
+24% +$190K 0.72% 26
2021
Q4 		$897 Hold
15,192
– – 0.53% 28
2021
Q3 		$653K Buy
15,192
+250
+2% +$11.1K 0.69% 32
2021
Q2 		$585K Hold
14,942
– – 0.62% 33
2021
Q1 		$541K Hold
14,942
– – 0.6% 34
2020
Q4 		$550K Sell
14,942
-888
-6% -$32.6K 0.61% 33
2020
Q3 		$551K Sell
15,830
-264
-2% -$9.26K 0.63% 33
2020
Q2 		$499K Hold
16,094
– – 0.48% 40
2020
Q1 		$498K Sell
16,094
-7,460
-32% -$254K 0.48% 34
2019
Q4 		$876K Sell
23,554
-7
-0% -$249 0.59% 32
2019
Q3 		$803K Hold
23,561
– – 0.56% 33
2019
Q2 		$968K Sell
23,561
-527
-2% -$20.9K 0.68% 25
2019
Q1 		$971K Buy
24,088
+88
+0.4% +$3.52K 0.73% 23
2018
Q4 		$994K Buy
+24,000
New +$996K 0.78% 22

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Riverview Trust Company's PFE Position: Q1 2026 in Review

Riverview Trust Company reduced its Pfizer (PFE) stake by 79% in Q1 2026, selling an estimated $31.8K and leaving 321 shares worth $9.01K. The position accounts for 0.01% of the portfolio, ranked #170.

Riverview Trust Company first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.2M in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Riverview Trust Company held 321 shares of Pfizer worth $9.01K as of Q1 2026.
  • Riverview Trust Company sold 1,193 Pfizer shares in Q1 2026, an estimated $31.8K.
  • Pfizer made up 0.01% of Riverview Trust Company's portfolio in Q1 2026, its #170 holding.
  • Riverview Trust Company first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Riverview Trust Company's Pfizer position peaked at $1.2M in Q2 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.